NHS England has supported two integrated care boards (ICBs) in the East of England to pilot local schemes to incentivise primary care networks to identify patients prescribed prophylactic antibiotics and invite those patients for a clinical review. Prescribing data will be used to monitor the impact of these pilot schemes and, if safe and effective, underpin a national roll out of this approach.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2023-07-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-07-05T16:20:58.207Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-06-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Urinary Tract Infections"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government whether they have plans for trials across England of antibiotic cessation for those receiving prophylactic antibiotics for recurrent urinary tracts infection, as pioneered in Wales.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"} ], "uin" : "HL8808"} , {"_about" : "http://data.parliament.uk/resources/1471387", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1471387/answer", "answerText" : {"_value" : "
NHS England and NHS Improvement\u2019s urinary tract infection (UTI) reduction workstream was established as part of delivery of the \u2018UK 5-year action plan for antimicrobial resistance 2019 to 2024\u2019. This workstream aims to enhance prevention, support early and accurate diagnosis and improve the treatment of UTIs through identifying and adopting best practice and interventions for different populations in healthcare settings, including at home and in care homes.<\/p>
The workstream does not plan to produce specific findings, as it reports its ongoing work through NHS England and NHS Improvement\u2019s national antimicrobial resistance programme board on a quarterly basis. Progress against all workstreams under the current action plan will be developed in the next five-year plan, which is due to be published in 2024.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4447", "label" : {"_value" : "Biography information for Maggie Throup"} } , "answeringMemberConstituency" : {"_value" : "Erewash"} , "answeringMemberPrinted" : {"_value" : "Maggie Throup"} , "dateOfAnswer" : {"_value" : "2022-06-30", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-06-30T08:43:51.86Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-06-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Urinary Tract Infections"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the key aims are of NHS England\u2019s AMR Programme UTI delivery group; and what timelines are in place for the publication of the findings of that group.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4488", "label" : {"_value" : "Biography information for Martyn Day"} } , "tablingMemberConstituency" : {"_value" : "Linlithgow and East Falkirk"} , "tablingMemberPrinted" : [{"_value" : "Martyn Day"} ], "uin" : "20274"} , {"_about" : "http://data.parliament.uk/resources/1437487", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1437487/answer", "answerText" : {"_value" : "
There have been no specific discussions. NHS England and NHS Improvement advise that the NHS Standard Contract for 2022/23 continues to require providers to have regard to all relevant national guidance, including from the National Institute for Health and Care Excellence and guidance related to catheter-acquired urinary tract infections.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2022-03-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-03-09T14:05:36.18Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-03-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Urinary Tract Infections"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions he has had with the NHS Patient Safety Team on proposals to remove the requirement of providers to reference guidance that relates to catheter-acquired urinary tract infections, as set out in the draft NHS Standard Contract consultation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4488", "label" : {"_value" : "Biography information for Martyn Day"} } , "tablingMemberConstituency" : {"_value" : "Linlithgow and East Falkirk"} , "tablingMemberPrinted" : [{"_value" : "Martyn Day"} ], "uin" : "133234"} , {"_about" : "http://data.parliament.uk/resources/1366166", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1366166/answer", "answerText" : {"_value" : "
NHS England requires English hospital providers through the National Health Service Standard Contract to submit data detailing hospital activity relating to NHS-provided or NHS funded care. This data is collated and published by NHS Digital. It includes hospital admissions where the patient was diagnosed with urinary tract infection. This can be found in the annual Hospital Episode Statistics (HES) Admitted Patient Care (APC) dataset at the following link: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity<\/a><\/p> Separately, the United Kingdom Health Security Agency undertakes surveillance of bloodstream infections in hospital and community settings, including information on the infection source through NHS acute trusts reporting infection cases.<\/p> NHS safety thermometer data collection was stopped in March 2020 due to emerging evidence that the data collected was incomplete and not being used as intended to support safety improvement and in part to support the COVID-19 response by freeing up nursing time.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2021-11-11", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "69662"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-11-11T11:04:48.783Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-11-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Urinary Tract Infections"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what data on urinary tract infection instance in clinical settings is being centrally collated by (a) NHS England, (b) his Department and (c) the UK Health Security Agency, given that this data is now primarily gathered at a local level.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
}
, "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
, "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
], "uin" : "69661"}
, {"_about" : "http://data.parliament.uk/resources/1366167", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1366167/answer", "answerText" : {"_value" : " NHS England requires English hospital providers through the National Health Service Standard Contract to submit data detailing hospital activity relating to NHS-provided or NHS funded care. This data is collated and published by NHS Digital. It includes hospital admissions where the patient was diagnosed with urinary tract infection. This can be found in the annual Hospital Episode Statistics (HES) Admitted Patient Care (APC) dataset at the following link: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity<\/a><\/p> Separately, the United Kingdom Health Security Agency undertakes surveillance of bloodstream infections in hospital and community settings, including information on the infection source through NHS acute trusts reporting infection cases.<\/p> NHS safety thermometer data collection was stopped in March 2020 due to emerging evidence that the data collected was incomplete and not being used as intended to support safety improvement and in part to support the COVID-19 response by freeing up nursing time.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2021-11-11", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "69661"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-11-11T11:04:48.817Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-11-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Urinary Tract Infections"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how data on urinary tract infection instance in clinical settings is being collated at a national level, following the suspension of the National Safety Thermometer and the move to data collection at Trust level.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
}
, "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
, "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
], "uin" : "69662"}
, {"_about" : "http://data.parliament.uk/resources/1237241", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1237241/answer", "answerText" : {"_value" : " Public Health England\u2019s (PHE\u2019s) continuous routine laboratory surveillance does not include device use or procedures associated with urinary infections, such as urinary catheters. Therefore, no estimate has been made of the number of catheter-acquired urinary tract infections (CAUTIs) which develop into a gram-negative bloodstream infection.<\/p> No assessment has been made on the effect of CAUTIs on antimicrobial resistance and antibiotic over-prescription.<\/p> However, PHE\u2019s English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) is working with the National Health Service and across sectors, to develop and maintain surveillance systems for monitoring trends in antimicrobial use and resistance in England. Further details are available in the ESPAUR report 2018-19 at the following link:<\/p> https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
}
, "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
, "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
, "dateOfAnswer" : {"_value" : "2020-10-22", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "94468"}
, {"_value" : "94470"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-10-22T16:03:01.167Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2020-09-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Urinary Tract Infections"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of catheter acquired urinary tract infections which develop into a gram negative bloodstream infection; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
}
, "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
, "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
], "uin" : "94467"}
, {"_about" : "http://data.parliament.uk/resources/1237242", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1237242/answer", "answerText" : {"_value" : " Public Health England\u2019s (PHE\u2019s) continuous routine laboratory surveillance does not include device use or procedures associated with urinary infections, such as urinary catheters. Therefore, no estimate has been made of the number of catheter-acquired urinary tract infections (CAUTIs) which develop into a gram-negative bloodstream infection.<\/p> No assessment has been made on the effect of CAUTIs on antimicrobial resistance and antibiotic over-prescription.<\/p> However, PHE\u2019s English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) is working with the National Health Service and across sectors, to develop and maintain surveillance systems for monitoring trends in antimicrobial use and resistance in England. Further details are available in the ESPAUR report 2018-19 at the following link:<\/p>